Latest Acral lentiginous melanoma Stories
Scientific investigators at five institutions receive $1 million to spur better outcomes for patients with acral melanoma and provide breakthroughs through the use of genome sequencing.
A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.
Scientists in Australia are reporting development and testing in laboratory animals of a potential new material for diagnosing malignant melanoma, the most serious form of skin cancer.
Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced that patient accrual in the MelaFind(R) pivotal trial was completed last week.
Individuals diagnosed with a first malignant melanoma of the skin have a significantly increased risk of being diagnosed with a second malignant melanoma, according to a report in the current issue of the International Journal of Cancer.
As with other cancers, scientists are learning that not all melanoma skin cancers are genetically alike. And that may have far-reaching implications for the treatment and prevention of melanoma.
New research published online by the BMJ today (Thursday 4 August 2005) suggests that melanoma is being overdiagnosed in the United States.
Despite campaigns promoting early detection and increased awareness of melanoma (skin cancer) the proportion of the most aggressive and deadly form of melanoma remains the same, according to an article in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.
- A woman chauffeur.
- A woman who operates an automobile.